BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Otsuka Pharmaceuticals UK Ltd 

Commonwealth House
2 Chalkhill Road
Hammersmith  London  W6 8DW  United Kingdom
Phone: 44-20-8600-6770 Fax: 44-20-8600-6794


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Sosei Co., Ltd. In-License Urology Drug From Otsuka Pharmaceutical Co., Ltd.10/19/2005 5:12:48 PM
Otsuka Pharmaceutical Co., Ltd. , Galenea Conclude Collaborate Research And Licensing Agreement10/19/2005 5:12:45 PM
Galenea Signs Collaboration And License Agreement With Otsuka Pharmaceutical Co., Ltd.10/19/2005 5:12:44 PM
Otsuka Pharmaceutical Co., Ltd. Grants Exclusive Rights To Develop And Market Rebamipide To Novartis Pharma AG (NVS)10/19/2005 5:12:39 PM
Novartis Pharma AG (NVS) Obtains Rights From Otsuka Pharmaceutical Co., Ltd. To Develop New Treatment For Dry Eye10/19/2005 5:12:38 PM
Otsuka And Prasco Laboratories Sign A Commercial Supply Agreement For PLETAL Tablets10/19/2005 5:11:51 PM
Bristol-Myers Squibb Company (BMY) And Otsuka Pharmaceutical Co., Ltd. Release: ABILIFY(R) (aripiprazole) Approved For Marketing In Europe For The Treatment Of Schizophrenia10/19/2005 5:11:37 PM
Otsuka Pharmaceuticals UK Ltd Selects Britannia Pharmaceuticals Limited To Distribute Adacolumn In The United Kingdom; Novel Treatment For Inflammatory Related Diseases Provides A Significant Alternative To Other Pharmaceutical Therapies10/19/2005 5:10:55 PM
Otsuka Pharmaceutical Co., Ltd.'s Antipsychotic Medication Approved For Marketing In Europe10/19/2005 5:08:42 PM